Dr Megan Lenardon is a medical mycologist and microbiology educator at the University of New South Wales (UNSW) in Sydney, Australia. She completed her BSc (Hons) in microbiology and PhD in yeast molecular genetics at UNSW before moving to the world-renowned Aberdeen Fungal Group in the UK to work on the fungal pathogen Candida albicans - one of the World Health Organisation’s four critical group fungal priority pathogens. Megan has studied the cell and molecular biology of C. albicans for 20 years and is an internationally recognised expert of fungal cell wall structure and biosynthesis. Since returning to UNSW in 2017, research in her group has been focussed on developing novel microbiome-based therapeutics to prevent life-threatening invasive C. albicans infections and antifungal polymers to treat C. albicans infections.